Summary
- Current Price
- As of today, DRMA price is $1.29, up +7.50% on
- Current Price All-Time High
- DRMA price is currently -99.99% below its historical high of $16,680.00 set on
- Market Cap
- DRMA current market cap is $4M, down -30.93% year-over-year
- PE Ratio
- DRMA PE ratio is unknown
- Revenue
- DRMA current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for DRMA has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Dermata Therapeutics, Inc. |
| Ticker | NASDAQ: DRMA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | dermatarx.com |
| Employees | 8 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.29 | ||
| Price, 1D Change | +7.50% | |
| $4M | ||
| - | ||
| - | ||
| 0.67 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$8.16 | ||
| EPS, 1Y Change | +89.84% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$8.16 | ||
| EPS Estimate | N/A | -$2.20 |
| EPS Est. Change | N/A | +73.04% |
| $0.00 | ||
| Revenue Estimate | N/A | $100.00K |
| Revenue Est. Change | N/A | - |
| $1.29 | ||
| Price Target | - | $4.00 |
| Price Tgt. Change | - | +210.08% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$15.24 | -$80.32 | -427.05% | |
| -$8.00 | -$8.16 | -2.01% | |
| -$2.20 | N/A | +73.04% | |
| -$1.49 | N/A | +81.74% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $100.00K | N/A | - | |
| $750.00K | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -86.97% | ||
| -99.33% | ||
| -30.93% | ||
| +34.08% | ||
| 0.00% | ||
| 0.00% | ||
| +89.84% | ||
| +96.09% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.29 | ||
| $3.80 | ||
| SMA 200 vs Price | +194.78% | |
| $1.54 | ||
| SMA 50 vs Price | +19.63% | |
| 0.67 | ||
| $0.17 | ||
| 47.47 | ||
| 153.76% | ||
| 121.73% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$8.16 | ||
| $0.00 | ||
| - | ||
| -$7.77M | ||
| - | ||
| -$7.56M | ||
| - | ||
| -$7.77M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 4.79 | ||
| 4.79 | ||
| - | ||
| - | ||
| -13.84 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.66 | ||
| 0.44 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $6.22M | ||
| $7.52M | ||
| $7.86M | ||
| $7.86M | ||
| $1.64M | ||
| $1.64M | ||
| $0.00 | ||
| $0.00 | ||
| $460.80K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $7.56M | ||
| $7.77M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$7.76M | ||
| $0.00 | ||
| $12.12M | ||
| $0.00 | ||
| -$7.76M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Maxim Group | → | |
| Maxim Group | → | |
| Maxim Group | → | |
| Maxim Group | ||
| Brookline Capital | ||
| Maxim Group |
Analyst sentiment
Institutional ownership
Screeners with DRMA
FAQ
What is the ticker symbol for Dermata Therapeutics, Inc.?
The ticker symbol for Dermata Therapeutics, Inc. is NASDAQ:DRMA
Does Dermata Therapeutics, Inc. pay dividends?
No, Dermata Therapeutics, Inc. does not pay dividends
What sector is Dermata Therapeutics, Inc. in?
Dermata Therapeutics, Inc. is in the Healthcare sector
What industry is Dermata Therapeutics, Inc. in?
Dermata Therapeutics, Inc. is in the Biotechnology industry
What country is Dermata Therapeutics, Inc. based in?
Dermata Therapeutics, Inc. is headquartered in United States
When did Dermata Therapeutics, Inc. go public?
Dermata Therapeutics, Inc. initial public offering (IPO) was on August 13, 2021
Is Dermata Therapeutics, Inc. in the S&P 500?
No, Dermata Therapeutics, Inc. is not included in the S&P 500 index
Is Dermata Therapeutics, Inc. in the NASDAQ 100?
No, Dermata Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Dermata Therapeutics, Inc. in the Dow Jones?
No, Dermata Therapeutics, Inc. is not included in the Dow Jones index
When was Dermata Therapeutics, Inc. last earnings report?
Dermata Therapeutics, Inc.'s most recent earnings report was on November 15, 2021
When does Dermata Therapeutics, Inc. report earnings?
The date for Dermata Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- DRMA Official Website www.dermatarx.com
- DRMA Profile on Yahoo Finance finance.yahoo.com/quote/DRMA
- DRMA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/drma